ELXR Stock Overview
Operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Elixxer Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.15 |
| 52 Week High | CA$1.15 |
| 52 Week Low | CA$1.15 |
| Beta | 0.87 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -23.33% |
| 5 Year Change | -85.63% |
| Change since IPO | -94.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ELXR | CA Capital Markets | CA Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | 2.2% |
| 1Y | n/a | 68.0% | 23.4% |
Return vs Industry: Insufficient data to determine how ELXR performed against the Canadian Capital Markets industry.
Return vs Market: Insufficient data to determine how ELXR performed against the Canadian Market.
Price Volatility
| ELXR volatility | |
|---|---|
| ELXR Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 5.4% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: ELXR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ELXR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Ferras Zalt | www.elixxer.com |
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd.
Elixxer Ltd. Fundamentals Summary
| ELXR fundamental statistics | |
|---|---|
| Market cap | CA$13.04m |
| Earnings (TTM) | -CA$6.17m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.1x
P/E RatioIs ELXR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELXR income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$6.17m |
| Earnings | -CA$6.17m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.54 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -104.8% |
How did ELXR perform over the long term?
See historical performance and comparison